跳至主要内容
临床试验/CTRI/2023/05/053262
CTRI/2023/05/053262尚未招募不适用

EFFECT OF PHALA GHRITA ON DEVELOPMENT OF OVARIAN FOLLICLE FOLLOWED BY BEEJOTSARGA (OVULATION) IN PATIENTS OF INFERTILITY DUE TO OVARIAN FACTOR IN COMPARISON WITH CLOMIPHENE CITRATE

MOHAN YENDE2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年6月19日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
2
主要终点
Beejotsarga (Ovulation)

研究概览

简要总结

Failure to ovulate is the major problem in India approximately 30% - 40% cases of female infertility. The Beeja is the core stone of the female reproductive process and absence of this factor Garbha cannot occur in spite of the proper Ritu, Kshetra and Ambu. Vagbhat stated the effect of Phalaghrita on Vandhyatva(infertility), so with an objective to study the effect of Phalaghruta in comparison with clomiphene citrate study will be carried out.  Materials and methods-This Single blind(participant) randomized control clinical involves two groups with 30 subjects each. Group A (Study Group)will be treated with administration of Phala Ghritain the dose of 10 ml B.D. orally with Anupana of cow milk 100 ml. Group B(Control Group)will be treated with administration of Tab. Clomiphene citrate50 mg O.D. orally for 5 days from day 3 to 7 of Menstrual cycle.

Expected outcome - Primary outcome of study will be development of follicle and Beejotsarga (ovulation) and Secondary outcome will be conception. Conclusion- Effect of drug Phala Ghrita will be stated as per observed result.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant Blinded

入排标准

年龄范围
19.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Married females unable to conceive from 1 year of active married life
  • Irregular or scanty menses due to anovulatory cycle
  • Anovulatory cycle
  • Unruptured ovarian follicle.

排除标准

  • Unmarried and non-fertile age group patients
  • Infertility other than ovarian causes e.g. cervical, uterine causes.
  • Cervical tumor, polyp, Ca cervix, Uterine fibroid
  • Congenital anomalies in female genital tract
  • Tubercular endometritis, Malignant and cytotoxic patients
  • HIV/VDRL/HbsAg positive
  • Non-Cooperative and patients.

结局指标

主要结局

Beejotsarga (Ovulation)

时间窗: Cycle 1TVS from day 10 | Cycle 2 TVS from day 10 | Cycle 3TVS from day 10

次要结局

  • Conception(after 28 day of cycle)

研究者

发起方
MOHAN YENDE
申办方类型
Other [self]

研究点 (2)

Loading locations...

相似试验